International Technidyne Corporation (THOR) Says CMS Decision to Expand Coverage for INR Self-Testing Will Increase the Market Opportunity for its ProTime(R) Microcoagulation System

4/8/2008 10:00:46 AM

EDISON, N.J.--(BUSINESS WIRE)--International Technidyne Corporation (ITC), a subsidiary of Thoratec Corporation (NASDAQ:THOR), today said the recent decision by the Centers for Medicare & Medicaid Services (CMS) to expand reimbursement for home prothrombin time monitoring will increase the market opportunity for its ProTime offering.

Read at BioSpace.com

Read Article at

Related Companies

News Categories

• BioSpace.com

• International Technidyne Corporation (ITC)

• Diagnostics

• Medical Dev. & Diag. - Industry